Related references
Note: Only part of the references are listed.Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
Jennifer O. Lauchle et al.
NATURE (2009)
Hematopoietic Cytokines Can Instruct Lineage Choice
Michael A. Rieger et al.
SCIENCE (2009)
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Amit J. Sabnis et al.
PLOS BIOLOGY (2009)
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
Stephen D. Barrett et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
P. D. Emanuel
LEUKEMIA (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function
Mark D. Trottier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Characterization of cancer stem cells in chronic myeloid leukaemia
H. G. Jorgensen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy
Cornelis J. H. Pronk et al.
CELL STEM CELL (2007)
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells
Margaret E. M. Van Meter et al.
BLOOD (2007)
Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration
Alan P. Brown et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo
Benjamin S. Braun et al.
BLOOD (2006)
Mechanisms of drug inhibition of signalling molecules
Judith S. Sebolt-Leopold et al.
NATURE (2006)
Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells
CC Zhang et al.
BLOOD (2004)
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
IT Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
BS Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors
J Zhang et al.
BLOOD (2004)
Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition
C Dorrell et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life
E Hellström-Lindberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
K Akashi et al.
NATURE (2000)